List of Excipients in API semaglutide
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing semaglutide
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Novo Nordisk | OZEMPIC | semaglutide | 0169-4136 | PHENOL | 2031-12-05 |
| Novo Nordisk | OZEMPIC | semaglutide | 0169-4136 | PROPYLENE GLYCOL | 2031-12-05 |
| Novo Nordisk | OZEMPIC | semaglutide | 0169-4136 | SODIUM PHOSPHATE, DIBASIC, DIHYDRATE | 2031-12-05 |
| Novo Nordisk | OZEMPIC | semaglutide | 0169-4136 | WATER | 2031-12-05 |
| Novo Nordisk | WEGOVY | semaglutide | 0169-4525 | SODIUM CHLORIDE | 2031-12-05 |
| Novo Nordisk | WEGOVY | semaglutide | 0169-4525 | SODIUM PHOSPHATE, DIBASIC, DIHYDRATE | 2031-12-05 |
| Novo Nordisk | WEGOVY | semaglutide | 0169-4525 | WATER | 2031-12-05 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for semaglutide
Excipient focus: PHENOL
semaglutide drug variants containing PHENOL
semaglutide drug variants not containing PHENOL
| Company | Ingredient | NDC |
|---|---|---|
| Novo Nordisk | semaglutide | 0169-4525 |
| A-S Medication Solutions | semaglutide | 50090-5824 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
semaglutide drug variants containing PROPYLENE GLYCOL
semaglutide drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Novo Nordisk | semaglutide | 0169-4525 |
| A-S Medication Solutions | semaglutide | 50090-5824 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CHLORIDE
semaglutide drug variants containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Novo Nordisk | semaglutide | 0169-4525 |
| A-S Medication Solutions | semaglutide | 50090-5824 |
| >Company | >Ingredient | >NDC |
semaglutide drug variants not containing SODIUM CHLORIDE
Excipient focus: SODIUM PHOSPHATE, DIBASIC, DIHYDRATE
semaglutide drug variants containing SODIUM PHOSPHATE, DIBASIC, DIHYDRATE
semaglutide drug variants not containing SODIUM PHOSPHATE, DIBASIC, DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
semaglutide drug variants containing WATER
semaglutide drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
